| 标题 |
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lung Cancer 作者:Luis Paz‐Ares; Rémi Veillon; Margarita Majem; Caicun Zhou; Kejing Tang; et al 出版日期:2025-10-03 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)